U.S. Online Retail and Ecommerce Stock News

Morgan Stanley (MS) is back in focus after fourth quarter earnings beat expectations, with wealth management and institutional securities driving the result, and a 6% share price jump underscoring renewed investor attention. See our latest analysis for Morgan Stanley. Those results sit against a share price of $183.05, with a 90 day share price return of 11.71% and a 1 year total shareholder return of 36.56%. This suggests momentum has been building, while recent earnings, capital returns and...

If you are wondering whether Amazon.com is truly good value at today’s price, you are not alone. This article will walk through the key numbers that matter. With the share price at US$234.34, Amazon.com has seen a 1.6% decline over the last 7 days, a 0.9% gain over 30 days, a 3.5% gain year to date, and a 0.5% decline over the last year, while the 3 year and 5 year returns sit at 136.2% and 44.8% respectively. These returns sit against an ongoing flow of news around Amazon.com's core e...

In January 2026, Butterfly Network, Inc. issued guidance indicating it expects at least 17% year-over-year revenue growth for the fourth quarter of 2025, prompting fresh attention from the analyst community. This guidance has highlighted the potential of Butterfly Network’s ultrasound platform across multiple business lines, drawing interest from both healthcare-focused and generalist investors. Next, we’ll explore how this outlook for at least 17% revenue growth shapes Butterfly Network’s...

Diversified Energy recently reported very large year-on-year revenue growth from its U.S. natural gas and liquids operations, while continuing to grapple with weak profitability and pressured earnings per share. At the same time, the company’s high dividend yield of 9.41% has drawn fresh investor attention, raising questions about how sustainable such payouts may be given its current earnings profile. Against this backdrop, we’ll examine how the combination of strong revenue growth and an...

Last week, Context Therapeutics Inc. ( NASDAQ:CNTX ) insiders, who had purchased shares in the previous 12 months were...

Dolby Laboratories (DLB) just released quarterly results, with revenue slightly ahead of expectations. However, its outlook for next quarter revenue and EPS came in much softer, creating a fresh focal point for investors. See our latest analysis for Dolby Laboratories. At a share price of $62.69, Dolby’s recent 1-month share price return of 5% and year to date share price return of 1.32% sit against a 1-year total shareholder return decline of 20.64%. This suggests momentum has softened even...

Mine disruption puts Nexa Resources (NEXA) in focus Nexa Resources (NEXA) temporarily halted production at its Atacocha San Gerardo open pit mine after the Joraoniyoc community blocked road access. The company is concentrating operations on essential maintenance with a reduced workforce. See our latest analysis for Nexa Resources. The production halt comes after a sharp run up, with Nexa Resources posting a 38.31% 30 day share price return and a 117.11% 90 day share price return, while its 1...

PACCAR (NasdaqGS:PCAR) announced the retirement of Executive Vice President C. Michael Dozier after 37 years with the company. Dozier’s retirement marks the departure of a long-serving leader involved in PACCAR’s senior management for multiple decades. The transition highlights a change in executive leadership that may be relevant for investors focused on governance and continuity. PACCAR, through brands such as Kenworth, Peterbilt, and DAF, is a major manufacturer in the global commercial...

Wondering if IQVIA Holdings is priced fairly right now, or if there could be value still on the table for you as an investor? IQVIA's share price last closed at US$239.05, with a 7 day return of 0.9% decline, a 30 day return of 6.2%, a year to date return of 6.1%, a 1 year return of 16.0% and a 3 year return of 4.6%, with a 5 year return of 33.8%. Recent news coverage has focused on IQVIA's role as a large player in data, analytics and services for the life sciences sector. This can shape...

Banco Latinoamericano de Comercio Exterior S. A (BLX) recently closed a US$150 million global syndicated loan led by Nexent Bank N.V., drawing ten participating institutions, a funding move that could be important for shareholders. See our latest analysis for Banco Latinoamericano de Comercio Exterior S. A. The stock has picked up some short term momentum, with a 1 month share price return of 7.60% and a year to date gain of 8.22%. The 1 year total shareholder return of 35.31% sits alongside...

If you are wondering whether CNH Industrial's current share price really reflects what the business is worth, you are not alone. This article is here to unpack that question in a clear way. The stock most recently closed at US$11.05, with returns of 2.1% over 7 days and 18.1% over 30 days, while the 1 year and 3 year returns of negative 12.3% and negative 30.9% show a very different picture to the 18.2% year to date gain. These mixed returns have put valuation back in focus for many...

STAAR Surgical (NasdaqGM:STAA) has reconstituted its Board of Directors and appointed Neal C. Bradsher as independent Board Chair. Three new directors have joined the Board, while two existing directors have stepped down. The Board has formed new committees, including a Search Committee to oversee the process of identifying a successor to the current CEO. The current CEO is expected to step down by the end of January 2026, establishing a defined leadership transition timeline. STAAR...

Third Coast Bancshares (TCBX) closed out FY 2025 with fourth quarter revenue of US$54.2 million and EPS of US$1.21, while on a trailing twelve month basis revenue reached US$201.3 million and EPS came in at US$4.45. The company has seen revenue move from US$158.9 million and EPS of US$2.85 on a trailing basis in Q3 2024 to US$201.3 million and EPS of US$4.45 by Q4 2025, alongside trailing net income rising from US$38.9 million to US$61.5 million over the same window. With net profit margins...

If you are wondering whether TG Therapeutics at around US$31.63 is offering fair value or an opportunity, it helps to start by grounding the share price in a clear valuation framework. The stock has returned 3.0% over the last 7 days, 2.9% over the past month, 8.0% year to date and 8.9% over the past year, while the 3 year return of 123.5% sits against a 5 year return of a 34.2% decline. Recent moves sit in the context of ongoing interest in TG Therapeutics and its product portfolio, as...

The SEC is investigating Jefferies Financial Group (NYSE:JEF) for potential securities law violations. The probe focuses on how the firm disclosed its exposure to the collapsed First Brands Group. Jefferies reported a loss tied to First Brands through its Point Bonita fund. The investigation centers on the adequacy and timing of Jefferies' disclosures to investors. Jefferies Financial Group, a diversified financial services company, is closely watched for its investment banking, trading,...

Event context and recent share performance TKO Group Holdings (TKO) has not been tied to a single headline event today, but the stock’s recent performance gives investors a few concrete data points to work with. Shares closed at US$200.13, with a 1 day return of roughly a 2.1% decline, a 7 day move of about a 4.2% decline, and a 1 month return of around a 7.2% decline, while the past 3 months show a 7.1% gain. See our latest analysis for TKO Group Holdings. That short term share price...

Why Ganesh Moorthy’s Appointment Matters for GlobalFoundries Stock GlobalFoundries (GFS) has drawn fresh attention after appointing Ganesh Moorthy, former president and CEO of Microchip Technology, to its board, a governance move that investors may view as strengthening leadership depth. See our latest analysis for GlobalFoundries. The appointment comes as GlobalFoundries’ share price has a 30 day share price return of 25.75% and a 90 day share price return of 27.42%, while the 3 year total...

Moderna and Merck released five year follow up data from the phase 2b KEYNOTE-942/mRNA-4157-P201 trial of their individualized mRNA melanoma vaccine combined with Keytruda. The results showed a durable, clinically meaningful reduction in the risk of cancer recurrence or death compared with Keytruda alone. The data support Moderna’s push into oncology and rare diseases and may influence future standards of care in melanoma as phase 3 studies progress. For investors watching NasdaqGS:MRNA,...

D-Wave Quantum (NYSE:QBTS) has completed its acquisition of Quantum Circuits, becoming the first company to offer both annealing and gate-model quantum systems. The company reports peer-reviewed quantum supremacy on a real-world problem using its new Advantage2 system. D-Wave has begun commercial sales of the Advantage2 prototype to leading research centers. D-Wave Quantum, trading at $27.43, now sits in a rare position as a dual-platform quantum computing provider through its combination...

Five Below reported past holiday-period net sales of about US$1.47 billion, up 23.2% year over year, with comparable sales growth of 14.5%, and raised its fourth-quarter and full-year 2025 guidance, including expected net sales of about US$1.71 billion for the quarter and US$4.75 billion for the year. The company’s willingness to increase its earnings outlook following this performance highlights management’s confidence in its value-focused model and merchandising strategy. Next, we will...

Casey's General Stores and Monster Energy are launching a limited time patriotic beverage in partnership. The collaboration includes a joint $200,000 donation to nonprofits supporting the military community. The initiative is positioned as both a product promotion and a community focused effort tied to military causes. For investors watching NasdaqGS:CASY, this campaign adds a fresh angle to the story of a convenience store operator that already has significant brand reach. The share price...

West Pharmaceutical Services (NYSE:WST) has agreed to sell all manufacturing and supply rights for its SmartDose 3.5mL On Body Delivery System to AbbVie. The deal covers only the 3.5mL version; West will continue to supply other SmartDose configurations. The agreement represents a notable shift in West's product portfolio and its role in large volume drug delivery partnerships. For you as an investor, this move sits at the core of what West does as a provider of drug delivery and packaging...

Archer-Daniels-Midland recently announced a US$26.00 million investment to expand production capacity and efficiency at its Erlanger, Kentucky campus, building on a prior US$15.00 million expansion plan, while also being recognized by FORTUNE as one of the world’s most admired food production companies for 2026. The focus on naturally derived color and flavor solutions for reformulated food and beverage products underscores how ADM is positioning its ingredients portfolio around cleaner...

Event overview and why Cellebrite DI (CLBT) is on watch Cellebrite DI (NasdaqGS:CLBT) has drawn fresh attention after scheduling its fourth quarter and full year 2025 earnings release for February 11, 2026, along with a conference call covering results and its 2026 outlook. See our latest analysis for Cellebrite DI. At a share price of US$15.82, Cellebrite DI has seen a 16.2% 30 day share price decline and a 32.5% 1 year total shareholder return loss. Its roughly 3x 3 year total shareholder...